ADVFN - Advanced Financial Network.
HOME» NYSE » M » MDT Stock Price » MDT Stock News

Medtronic Share News

 Medtronic, Inc. Stock Price
MDT Stock Price
 Medtronic, Inc. Stock Chart
MDT Stock Chart
 Medtronic, Inc. Stock News
MDT Stock News
 Medtronic, Inc. Company Information
MDT Company Information
 Medtronic, Inc. Stock Trades
MDT Stock Trades

Medtronic Issues Battery Depletion Advisory For Heart Devices

By Anjali Athavaley Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- A small percentage of Medtronic Inc.'s (MDT) heart devices may have problems where battery life depletes faster than expected, the company said in an online advisory earlier this week. Medtronic no longer sells the models in question. An estimated 39,000 EnTrust implantable defibrillators are implanted world-wide. Implantable defibrillators provide a shock to the heart when needed in patients with irregular heartbeat. The battery in the EnTrust devices is supposed to last at least three months after an elective replacement indicator comes on. Medtronic said that as of last month, there have been 60 confirmed events that involved a drop in battery voltage over a time period ranging from one week to six months. The company has identified the cause of the incidents to be a battery short that develops toward the end of the device's life. All reported events have occurred at least 30 months after implant. Medtronic shares were down 1% to $37.76 in recent trading. The stock is down 1.3% this year. No patient deaths or serious injuries have been reported. "Ongoing impact from the advisory appears limited," said Derrick Sung, an analyst at Bernstein, in a note Friday. He said the issue looks manageable. "Physicians need simply to replace the device as soon as the elective replacement indicator is reached." Medtronic isn't the only medical devices company that has dealt with battery problems in its heart rhythm devices. Competitor St. Jude Medical Inc. (STJ) faced similar concerns in a subset of its defibrillators late last year. The advisory comes as medical device makers face a challenging market for implantable defibrillators. Domestic sales have slumped on a Department of Justice investigation and a study published last year that indicated the devices were being used outside clinical guidelines. -By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

Stock News for Medtronic (MDT)
DateTimeHeadline
09/26/201608:01:27Medtronic's StealthStation® Cranial Software Receives FDA Clearance...
09/20/201612:30:12Medtronic Valiant Captivia Demonstrates Safety and Efficacy at...
09/19/201617:07:45Statement of Changes in Beneficial Ownership (4)
09/19/201616:46:54Statement of Changes in Beneficial Ownership (4)
09/19/201612:45:20New Data Presented in VIVA Late Breaking Clinical Trials Demonstrate...
09/19/201609:30:19Analysis Shows Positive Association Between Cardiac Resynchronization...
09/19/201607:00:00AxoGen, Inc. Appoints Amy Wendell to Board of Directors  
09/15/201608:30:29The Journal of the American Medical Association Publishes Medtronic's...
09/15/201608:00:46Medtronic Names Mark Ploof Senior Vice President of Global Operations...
09/14/201609:00:25Medtronic Announces Approval and Launch of Reveal LINQ(TM) Insertable...
09/13/201611:00:43Medtronic Receives FDA Approval of First Drug-Coated Balloon...
09/12/201609:00:12New ESC Guidelines Support Recent Medtronic Innovations for...
09/08/201612:55:35Medtronic Recognized as a Sustainability Leader
09/07/201606:48:16Quarterly Report (10-q)
09/06/201609:00:20Medtronic CEO Omar Ishrak to Speak at Morgan Stanley Global Healthcare...
09/01/201610:00:16Medtronic EVP & RTG President Geoff Martha to Speak at Wells...
09/01/201609:00:14Medtronic Announces Approval of Enlite® Sensor for iPro®2 Professional C...
08/31/201615:25:54Statement of Changes in Beneficial Ownership (4)
08/29/201609:00:09Medtronic Technologies Improve Delivery of Cardiac Resynchronization...
08/28/201610:30:39New Long-Term Data Reinforce Safety Benefits of the World's Smallest...

Medtronic and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad